ArticleSurgical endoscopy2026
Hybrid endoscopic submucosal dissection reduces procedure time for superficial esophageal squamous carcinomas ≤ 2 cm: a single-center retrospective propensity score-matched analysis.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundConventional endoscopic submucosal dissection (C-ESD) for esophageal neoplastic lesions is challenging and time-consuming. Hybrid ESD (H-ESD) is a simplified ESD technique involving lesion marking, followed by circumferential incision and appropriate submucosal dissection, and, finally, lesions are resected using a single snare. Evidence regarding its use in esophageal cancer remains limited. In this single-center study, we aimed to compare the efficacy and safety of H-ESD with those of conventional ESD for superficial esophageal squamous carcinomas ≤2 cm.
methodsWe retrospectively reviewed patients with superficial esophageal squamous carcinomas who underwent ESD at our center between January 2022 and August 2025. The primary outcome was procedure time. The secondary outcomes included resection speed, R0 resection rate, en bloc resection rate, and incidence of adverse events.
resultsA total of 381 patients were included. Following 1:2 propensity score matching, 25 and 50 patients were allocated to the H-ESD and C-ESD groups, respectively. The average procedure time in the H-ESD group was significantly shorter than that in the C-ESD group (9.44±5.78 min vs. 28.72±19.20 min, p<0.001). The resection speed was faster in the H-ESD group than in the C-ESD group (0.30±0.16 cm
conclusionsCompared with C-ESD, H-ESD is associated with shorter procedure time and faster resection speed. Therefore, H-ESD is an alternative endoscopic treatment for superficial esophageal squamous carcinomas ≤2 cm ESD.
Indexed as
Identifiers
42816636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.